Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Cadrenal Therapeutics, Inc. (CVKD – Research Report) today and set a price ...

Noble Financial analyst Mark Reichman maintained a Buy rating on Freightcar America (RAIL – Research Report) today and set a price target of ...

Equities research analysts at Noble Financial dropped their Q1 2025 earnings per share estimates for shares of Comstock in a research note issued on Monday, March 10th. Noble Financial analyst M.

Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued to clients and investors on Tuesday, March 11th. Noble ...

Barnes & Noble Education's business is highly seasonal, with the major portion of sales and operating profit realized during ...

Barnes & Noble Education’s business is highly seasonal, with the major portion of sales and operating profit realized during the second and third fiscal quarters. Q3 and YTD FY2025 Financial ...

Full quarterly financial tables and a reconciliation of ... Form 8-K filed with the SEC on the date of this release. Barnes & Noble Education’s business is highly seasonal, with the major ...

Barnes & Noble Education, Inc. announced its financial results for the third quarter of fiscal year 2025, showing a 2.1% increase in revenue to $466.3 million, primarily driven by a 21% year-over ...

Full quarterly financial tables and a reconciliation of non-GAAP measures to the most applicable GAAP measures can be found in Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the ...

Christopher Neumann will serve in the same capacity for the Basking Ridge-based company, which is one of the largest ...